Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1314
| Despition | Syndecan-1 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1452 | Human HSD17B1 Protein (AC1452) | 2 µg | inquiry |
| ACPP-1683 | Human RCAN2 Protein (AC1683) | 5 µg | inquiry |
| ACPP-1108 | Recombinant Human CD34 Protein (6×His Tag) (AC1108) | 50 µg | inquiry |
| ACPP-1290 | Insulin Receptor Blocking Peptide (AC1290) | 250 µg | inquiry |
| ACPP-1612 | Human Vimentin Protein, GST (AC1612) | 2 µg | inquiry |
| ACPP-1009 | Recombinant Human TYRO3 Protein (6×His Tag) (AC1009) | 50 µg | inquiry |
| ACPP-1392 | Human Dopa Decarboxylase Protein (AC1392) | 5 µg | inquiry |
| ACPP-1599 | Human CHGB Protein (AC1599) | 2 µg | inquiry |
| ACPP-1292 | Nkx2.2 Blocking Peptide (AC1292) | 250 µg | inquiry |
| ACPP-1044 | Recombinant Human RAGE Protein (6×His Tag) (AC1044) | 50 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.